Nutritional Assessment + Short-Term Fasting + Metformin hydrochloride for carcinoma, intraductal, noninfiltrating

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 27 Aug 2021: Trial registered, NCT05023967
  2. 4 Apr 2023: Trial started, NCT05023967

The trials

NCT05023967: Metformin and Nightly Fasting in Women With Early Breast Cancer

State
Under way
Phase
Phase 2
People
120 taking part
Started
4 Apr 2023
Primary completion
9 Dec 2025
Arms
Arm I (fasting, glucose monitoring, counseling, metformin)
Results
None posted
  1. 27 Aug 2021: Trial registered
  2. 4 Apr 2023: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.